law.justia.com/cases/maryland/court-of-special-appeals/1990/940-september-term-1989-0.html

81 Md. App. 345 (1990). 567 A.2d 524. SYLVESTER FRANKLIN, JR. v. SHANKER L. GUPTA, ET AL. No. 940, September Term, 1989. Court of Special Appeals ...

www.researchgate.net/profile/Jennifer_Van_Velkinburgh3

van Velkinburgh Initiative for Collaboratory Biomedical Research. Santa Fe, New Mexico, ...... No probes met this cutoff for the S. aureus vs. ...... Goutam Gupta.

maglobal.com/team/sara-van-velkinburgh

Sara Van Velkinburgh, Associate, supports our Mexico, Central America, Caribbean and the Andean region practices. Sara graduated from Boston University's ...

www.linkedin.com/in/thomasvanvelkinburgh

View Thomas Van Velkinburgh's profile on LinkedIn, the world's largest professional community. Thomas has 8 jobs listed on their profile. See the complete ...

journals.plos.org/plosone/article?id=10.1371/journal.pone.0175686

Apr 20, 2017 ... Citation: Gupta S, Seydel K, Miranda-Roman MA, Feintuch CM, Saidi A, .... Phenylalanine was also increased during CM (128 µM vs 54 µM, ..... Langley RJ, Tsalik EL, van Velkinburgh JC, Glickman SW, Rice BJ, Wang C, et al.

journals.plos.org/plosone/article?id=10.1371/journal.pone.0048979

Jan 9, 2013 ... Citation: Ahn SH, Tsalik EL, Cyr DD, Zhang Y, van Velkinburgh JC, ... a variety of conditions including severe infection [21], bacterial vs. viral illness [10], ...... Dziarski R, Wang Q, Miyake K, Kirschning CJ, Gupta D (2001) MD-2 ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC5398544

Phenylalanine was also increased during CM (128 µM vs 54 µM, p = 0.008), ..... Pappa V, Seydel K, Gupta S, Feintuch CM, Potchen MJ, Kampondeni S, et al. .... Langley RJ, Tsalik EL, van Velkinburgh JC, Glickman SW, Rice BJ, Wang C, et al.

health.usnews.com/doctors/emanuel-rivers-12214

Dr. Emanuel Rivers is an emergency medicine physician in Detroit, Michigan and is affiliated with John D. Dingell Veterans Affairs Medical Center. He received ...

onlinelibrary.wiley.com/doi/abs/10.1111/j.1553-2712.2010.00664.x

Apr 2, 2010 ... Early progression to shock (vs. no progression) was associated with higher 30‐ day mortality (13.1% vs. 3.1%, odds ratio [OR] = 4.72, 95% ...